Ercan Z S, Bor N M, Torunoğlu M, Türker R K
Arzneimittelforschung. 1982;32(1):30-1.
Pure kallikrein and bradykinin, when added to the perfusion medium of the isolated perfused rat lung, produced an equal inhibition in the conversion of angiotensin I to angiotensin II as measured in the venous return superfused over the rabbit aortic strips. Acetylsalicylic acid (ASA) prevented the inhibitory effect of kallikrein and bradykinin. Aprotinin, however, prevented the inhibitory effect of kallikrein without altering that of bradykinin. The recovery brought about by ASA of the bradykinin-produced inhibition of angiotensin I conversion was also prevented by prior addition of prostaglandin E2 (PGE2) into the perfusion medium. Neither kallikrein and bradykinin nor ASA altered the myotropic activity of angiotensin II. 5-Oxo-L-prolyl L-tryptophyl-L-prolyl-L-arginyl-L-prolyl-L-glutaminyl-L-isoleucyl-L-prolyl-L- proline (SQ 20 881), when added to the medium, greatly reduced the responses to angiotensin I but potentiated those of angiotensin II. The possible mechanisms of the inhibitory effects of kallikrein and bradykinin are discussed.
当将纯激肽释放酶和缓激肽添加到离体灌注大鼠肺的灌注介质中时,在兔主动脉条上超灌注的静脉回流中所测得的血管紧张素I向血管紧张素II的转化受到同等程度的抑制。乙酰水杨酸(ASA)可阻止激肽释放酶和缓激肽的抑制作用。然而,抑肽酶可阻止激肽释放酶的抑制作用,而不改变缓激肽的抑制作用。在灌注介质中预先加入前列腺素E2(PGE2)也可阻止ASA对缓激肽所致血管紧张素I转化抑制作用的恢复。激肽释放酶、缓激肽以及ASA均未改变血管紧张素II的肌otropic活性。当将5-氧代-L-脯氨酰-L-色氨酰-L-脯氨酰-L-精氨酰-L-脯氨酰-L-谷氨酰胺基-L-异亮氨酰-L-脯氨酰-L-脯氨酸(SQ 20 881)添加到介质中时,可大大降低对血管紧张素I的反应,但增强对血管紧张素II的反应。文中讨论了激肽释放酶和缓激肽抑制作用的可能机制。